Transcript Curriculum Vitae of Lucia Del Mastro

Lucia Del Mastro
Oncology, A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)
SciVal Experts URL: http://www.experts.scival.com/moh-it/expert.asp?n=Lucia+Del+Mastro&u_id=666
136 Publications
2016
2016
2016
2016
2016
2016
2016
Matteo Lambertini; Paolo Bruzzi; Francesca Poggio; Simona Pastorino; Giovanni Gardin; Matteo
Clavarezza; Claudia Bighin; Paolo Pronzato; Lucia Del Mastro
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and
taxane-based chemotherapy in breast cancer patients: a single-center experience within
the GIM2 randomized phase III trial
Supportive Care in Cancer. 2016;24(3):1285-1294. Matteo Lambertini; Paola Anserini; Lucia Del Mastro
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young
breast cancer survivors?
European Journal of Cancer. 2016;54:163-164. Filippo Montemurro; Lucia Del Mastro; Michele De Laurentiis; Fabio Puglisi
Endocrine therapy in premenopausal women with breast cancer: A critical appraisal of
current evidence
Expert Review of Anticancer Therapy. 2016;16(2):211-218. Silvia Boero; Anna Morabito; Barbara Banelli; Barbara Cardinali; Beatrice Dozin; Gianluigi Lunardi;
Patrizia Piccioli; Sonia Lastraioli; Roberta Carosio; Sandra Salvi; Alessia Levaggi; Francesca Poggio;
Alessia D'Alonzo; Massimo Romani; Lucia Mastro; Alessandro Poggi; Maria Pia Pistillo
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: Possible
relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast
cancer cell lines
Journal of Translational Medicine. 2016. Matteo Lambertini; Lucia Del Mastro; Maria C. Pescio; Claus Y. Andersen; Hatem A. Azim; Fedro A.
Peccatori; Mauro Costa; Alberto Revelli; Francesca Salvagno; Alessandra Gennari; Filippo M. Ubaldi;
Giovanni B. La Sala; Cristofaro De Stefano; W.Hamish Wallace; Ann H. Partridge; Paola Anserini
Cancer and fertility preservation: International recommendations from an expert meeting
BMC Medicine. 2016;14(1). Lucia Del Mastro; Alessia Levaggi; Andrea Michelotti; Giovanna Cavazzini; Francesca Adami; Tiziana
Scotto; Margherita Piras; Saverio Danese; Ornella Garrone; Antonio Durando; Valeria Accortanzo;
Claudia Bighin; Loredana Miglietta; Simona Pastorino; Paolo Pronzato; Federico Castiglione; Elisabetta
Landucci; PierFranco Conte; Paolo Bruzzi
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in
node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial
Breast Cancer Research and Treatment. 2016;155(1):117-126. Lucia Del Mastro; Giovanni Rossi; Matteo Lambertini; Francesca Poggio; Paolo Pronzato
New insights on the role of luteinizing hormone releasing hormone agonists in
premenopausal early breast cancer patients
Cancer Treatment Reviews. 2016;42:18-23. 2015
2015
2015
2015
2015
2015
Matteo Lambertini; Luca Boni; Andrea Michelotti; Teresa Gamucci; Tiziana Scotto; Stefania Gori; Monica
Giordano; Ornella Garrone; Alessia Levaggi; Francesca Poggio; Sara Giraudi; Claudia Bighin; Carlo
Vecchio; Mario Roberto Sertoli; Paolo Pronzato; Lucia Del Mastro
Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and
long-term ovarian function, pregnancies, and disease-free survival a randomized clinical
trial
JAMA - Journal of the American Medical Association. 2015;314(24):2632-2640. M. Lambertini; M. Ceppi; F. Poggio; F.A. Peccatori; H.A. Azim; D. Ugolini; P. Pronzato; S. Loibl; H.C.F.
Moore; A.H. Partridge; P. Bruzzi; L. Del Mastro
Ovarian suppression using luteinizing hormonereleasing hormone agonists during
chemotherapy to preserve ovarian function and fertility of breast cancer patients: A
meta-analysis of randomized studies
Annals of Oncology. 2015;26(12):2408-2419. Matteo Lambertini; Arlindo R Ferreira; Lucia Del Mastro; Romano Danesi; Paolo Pronzato
Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients
with solid tumors
Expert Opinion on Biological Therapy. 2015. Lucia Del Mastro; Matteo Lambertini
Temporary ovarian suppression with gonadotropin-releasing hormone agonist during
chemotherapy for fertility preservation: Toward the end of the debate?
Oncologist. 2015;20(11):1233-1235. Silvia Boero; Anna Morabito; Barbara Banelli; Barbara Cardinali; Beatrice Dozin; Gianluigi Lunardi;
Patrizia Piccioli; Sonia Lastraioli; Roberta Carosio; Sandra Salvi; Alessia Levaggi; Francesca Poggio;
Alessia D'Alonzo; Massimo Romani; Lucia Mastro; Alessandro Poggi; Maria Pia Pistillo
Analysis of in vitro ADCC and clinical response to trastuzumab: Possible relevance of
FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell
lines
Journal of Translational Medicine. 2015;13(1). Matteo Lambertini; Francesca Poggio; Alessia Levaggi; Lucia Del Mastro
Protecting ovaries during chemotherapy through gonad suppression: A systematic review
and meta-analysis
Obstetrics and Gynecology. 2015;126(4):901. 2015
Matteo Lambertini; Nermine S Kamal; Fedro A Peccatori; Lucia Del Mastro; Hatem A Azim
Exploring the safety of chemotherapy for treating breast cancer during pregnancy
Expert Opinion on Drug Safety. 2015;14(9):1395-1408. 2015
2015
Lucia Del Mastro; Marina Cazzaniga; Paolo Solidoro; Daniele Generali; Giulia Bianchi; Franco Testore;
Sabino De Placido
Everolimus-based therapy in patients with hormone receptor-positive,
HER2<sup>-</sup> advanced breast cancer: Management considerations
Future Oncology. 2015;11(16):2251-2254. Giuseppe Bogina; Gianluigi Lunardi; Francesca Coati; Giuseppe Zamboni; Stefania Gori; Laura Bortesi;
Marcella Marconi; Paola Agnese Cassandrini; Monica Turazza; Laura Cortesi; Elisabetta DeMatteis; Guido
Ficarra; Toni Ibrahim; Patrizia Serra; Laura Medri; Sara Giraudi; Matteo Lambertini; Franca Carli;
Jennifer Foglietta; Angelo Sidoni; Martina Nunzi; Corrado Ficorella; Maria Rosaria Diadema; Lucia Del
Mastro
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen
receptor-positive locoregional recurrence
Tumori. 2015;101(4):398-403. 2015
2015
2015
2014
2014
2014
Lucia Del Mastro; Sabino De Placido; Paolo Bruzzi; Michele De Laurentiis; Corrado Boni; Giovanna
Cavazzini; Antonio Durando; Anna Turletti; Cecilia Nisticò; Enrichetta Valle; Ornella Garrone; Fabio
Puglisi; Filippo Montemurro; Sandro Barni; Andrea Ardizzoni; Teresa Gamucci; Giuseppe Colantuoni;
Mario Giuliano; Adriano Gravina; Paola Papaldo; Claudia Bighin; Giancarlo Bisagni; Valeria Forestieri;
Francesco Cognetti
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with
early-stage breast cancer: An open-label, 2 × 2 factorial, randomised phase 3 trial
The Lancet. 2015;385(9980):1863-1872. Stefania Gori; Jennifer Foglietta; Gianluigi Lunardi; Alessandro Inno; Barbara Cardinali; Enrico Millo;
Lucia Del Mastro; Emidio Giovanni Nunzi; Lucio Crinò
Pharmacokinetics of trastuzumab in haemodialysis
Breast Journal. 2015;21(3):329-331. Matteo Lambertini; Arlindo R. Ferreira; Francesca Poggio; Fabio Puglisi; Antonio Bernardo; Filippo
Montemurro; Elena Poletto; Emma Pozzi; Valentina Rossi; Emanuela Risi; Antonella Lai; Elisa Zanardi;
Valentina Sini; Serena Ziliani; Gabriele Minuti; Silvia Mura; Donatella Grasso; Andrea Fontana; Lucia del
Mastro
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in
HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant
trastuzumab: An Italian multicenter retrospective cohort study
Oncologist. 2015;20(8):880-889. Alessia Levaggi; Andrea De Maria; Beatrice Dozin; Giuseppina Iacono; Claudia Bighin; Sara Giraudi;
Matteo Lambertini; Alessia D'Alonzo; Francesca Poggio; Paolo Pronzato; Lucia Del Mastro
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during
chemotherapy for early breast cancer
Anticancer Research. 2014;34(7):3715-3720. Francesco Bertoldo; Franco Silvestris; Toni Ibrahim; Francesco Cognetti; Daniele Generali; Carla Ida
Ripamonti; Dino Amadori; Marco Angelo Colleoni; Pierfranco Conte; Lucia Del Mastro; Sabino De Placido;
Cinzia Ortega; Daniele Santini
Targeting bone metastatic cancer: Role of the mTOR pathway
Biochimica et Biophysica Acta - Reviews on Cancer. 2014;1845(2):248-254. V. Sini; G. Lunardi; M. Cirillo; M. Turazza; C. Bighin; S. Giraudi; A. Levaggi; P. Piccioli; G. Bisagni; R.
Gnoni; G. Stridi; M. Porpiglia; E. Picardo; R. Ponzone; D. Marenco; M. Mansutti; F. Puglisi; L. Del Mastro
Body mass index and circulating oestrone sulphate in women treated with adjuvant
letrozole
British Journal of Cancer. 2014;110(5):1133-1138. 2014
Claudia Bozza; Fabio Puglisi; Matteo Lambertini; Etin-Osa Osa; Massimo Manno; Lucia Del Mastro
Anti-Müllerian hormone: Determination of ovarian reserve in early breast cancer patients
Endocrine-Related Cancer. 2014;21(1):R51-R65. 2014
2014
S. Gori; G. Lunardi; A. Inno; J. Foglietta; B. Cardinali; L. Del mastro; L. Crinò
Lapatinib concentration in cerebrospinal fluid in two patients with her2-positive metastatic
breast cancer and brain metastases
Annals of Oncology. 2014;25(4):912-913. Lucia Del Mastro; Marcello Ceppi; Francesca Poggio; Claudia Bighin; Fedro Peccatori; Isabelle
Demeestere; Alessia Levaggi; Sara Giraudi; Matteo Lambertini; Alessia D'Alonzo; Giuseppe Canavese;
Paolo Pronzato; Paolo Bruzzi
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced
premature ovarian failure in cancer women: Systematic review and meta-analysis of
2014
2014
2014
randomized trials
Cancer Treatment Reviews. 2014;40(5):675-683. G. Canavese; P. Bruzzi; A. Catturich; C. Vecchio; D. Tomei; L. Del Mastro; F. Carli; M. Guenzi; F. Lacopo;
B. Dozin
A risk score model predictive of the presence of additional disease in the axilla in
early-breast cancer patients with one or two metastatic sentinel lymph nodes
European Journal of Surgical Oncology. 2014;40(7):835-842. Fabio Puglisi; Caterina Fontanella; Gianmauro Numico; Valentina Sini; Laura Evangelista; Francesco
Monetti; Stefania Gori; Lucia Del Mastro
Follow-up of patients with early breast cancer: Is it time to rewrite the story?
Critical Reviews in Oncology/Hematology. 2014;91(2):130-141. Barbara Cardinali; Gianluigi Lunardi; Enrico Millo; Andrea Armirotti; Gianluca Damonte; Aldo Profumo;
Stefania Gori; Giuseppina Iacono; Alessia Levaggi; Lucia Del Mastro
Trastuzumab quantification in serum: A new, rapid, robust ELISA assay based on a mimetic
peptide that specifically recognizes trastuzumab
Analytical and Bioanalytical Chemistry. 2014;406(18):4557-4561. 2014
Matteo Lambertini; Ana Catarina Pinto; Lucia Del Mastro
Fertility issues in young breast cancer patients: What women want
Journal of Thoracic Disease. 2014;6(6):584-588. 2014
Matteo Lambertini; Lucia Del Mastro; Andrea Bellodi; Paolo Pronzato
The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating
factors (G-CSFs)
Critical Reviews in Oncology/Hematology. 2014;89(1):112-128. 2013
Alessandra Gennari; Lucia Del Mastro
Anthracycline-free therapy for HER2-amplified breast cancer
The Lancet Oncology. 2013;14(11):1037-1038. 2013
2013
2013
2013
Matteo Clavarezza; Monica Turazza; Enrico Aitini; Silvana Saracchini; Ornella Garrone; Antonio Durando;
Sabino De Placido; Giancarlo Bisagni; Alessia Levaggi; Claudia Bighin; Eleonora Restuccia; Roberto
Scalamogna; Anna Galli; Lucia Del Mastro
Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and
taxane therapy for locally advanced breast cancer
Breast. 2013;22(4):470-475. Claudia Bighin; Paolo Pronzato; Lucia Del Mastro
Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer
patients
Future Oncology. 2013;9(7):955-957. Grazia Arpino; Daniele Generali; Anna Sapino; Del Matro Lucia; Antonio Frassoldati; Michelino de
Laurentis; Pronzato Paolo; Giorgio Mustacchi; Marina Cazzaniga; Sabino De Placido; Pierfranco Conte;
Mariarosa Cappelletti; Vanessa Zanoni; Andrea Antonelli; Mario Martinotti; Fabio Puglisi; Alfredo Berruti;
Alberto Bottini; Luigi Dogliotti
Gene expression profiling in breast cancer: A clinical perspective
Breast. 2013;22(2):109-120. Lucia Del Mastro; Alessandra Fabi; Mauro Mansutti; Michele De Laurentiis; Antonio Durando; Domenico
Franco Merlo; Paolo Bruzzi; Ignazia La Torre; Matteo Ceccarelli; Gbenga Kazeem; Paolo Marchi; Davide
Boy; Marco Venturini; Sabino De Placido; Francesco Cognetti
2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association
with docetaxel or paclitaxel in women with metastatic breast cancer: A comparison of
different schedules and treatments
BMC Cancer. 2013;13. G. Lunardi; P. Piccioli; P. Bruzzi; R. Notaro; S. Lastraioli; M. Serra; P. Marroni; C. Bighin; M. Mansutti; F.
Puglisi; M. Porpiglia; R. Ponzone; G. Bisagni; O. Garrone; G. Cavazzini; M. Clavarezza; L. Del Mastro
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in
postmenopausal women with early breast cancer treated with letrozole
Breast Cancer Research and Treatment. 2013;137(1):167-174. 2013
Matteo Lambertini; Paola Anserini; Alessia Levaggi; Francesca Poggio; Lucia Del Mastro
Fertility counseling of young breast cancer patients
Journal of Thoracic Disease. 2013;5(SUPPL.1):S68-S80. 2012
2012
2012
2011
2011
2011
2011
Lucia Del Mastro; Matteo Lambertini; Claudia Bighin; Alessia Levaggi; Alessia D'Alonzo; Sara Giraudi;
Paolo Pronzato
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients
Expert Review of Anticancer Therapy. 2012;12(11):1391-1405. Matteo Lambertini; Lucia Del Mastro; Giovanni Gardin; Alessia Levaggi; Claudia Bighin; Sara Giraudi;
Paolo Pronzato
Stevens-Johnson syndrome after treatment with bendamustine
Leukemia Research. 2012;36(7):e153-e154. Matteo Clavarezza; Giorgio Mustacchi; Andrea C. Gardini; Lucia Del Mastro; Andrea De Matteis;
Ferdinando Riccardi; Vincenzo Adamo; Enrico Aitini; Domenico Amoroso; Paolo Marchetti; Stefania Gori;
Francesco Carrozza; Evaristo Maiello; Francesco Giotta; Davide Dondi; Marco Venturini
Biological characterization and selection criteria of adjuvant chemotherapy for early breast
cancer: experience from the Italian observational NEMESI study
BMC Cancer. 2012;12:[216]. Lucia Del Mastro; Marco Venturini
Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer Reply
JAMA - Journal of the American Medical Association. 2011;306(16):1760-1761. Davide Bedognetti; Mario Roberto Sertoli; Paolo Pronzato; Lucia Del Mastro; Marco Venturini; Paola
Taveggia; Elisa Zanardi; Guido Siffredi; Simona Pastorino; Paola Queirolo; Giovanni Gardin; Ena Wang;
Clara Monzeglio; Francesco Boccardo; Paolo Bruzzi
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: A
multicenter randomized phase III trial
Journal of the National Cancer Institute. 2011;103(20):1529-1539. Lucia Del Mastro
Temporary ovarian suppression with goserelin and ovarian function protection in patients
with breast cancer undergoing chemotherapy
Journal of Clinical Oncology. 2011;29(24):3339-3340. G. Canavese; B. Dozin; C. Vecchio; D. Tomei; G. Villa; F. Carli; L. Del Mastro; A. Levaggi; C. Rossello; S.
Spinaci; P. Bruzzi; A. Catturich
Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with
locally advanced breast cancer and clinically positive axillary nodes
European Journal of Surgical Oncology. 2011;37(8):688-694. 2011
2011
2011
Marco Danova; Sandro Barni; Lucia Del Mastro; Romano Danesi; Giovanni L Pappagallo
Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for
solid tumors
Expert Review of Anticancer Therapy. 2011;11(8):1303-1313. Lucia Del Mastro; Luca Boni; Andrea Michelotti; Teresa Gamucci; Nina Olmeo; Stefania Gori; Monica
Giordano; Ornella Garrone; Paolo Pronzato; Claudia Bighin; Alessia Levaggi; Sara Giraudi; Nicola Cresti;
Emanuela Magnolfi; Tiziana Scotto; Carlo Vecchio; Marco Venturini
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of
chemotherapy-induced early menopause in premenopausal women with breast cancer: A
randomized trial
JAMA - Journal of the American Medical Association. 2011;306(3):269-276. Lucia Del Mastro; Alessia Levaggi; Sara Giraudi; Paolo Pronzato
Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast
cancer patients: Current role and future perspectives
Cancer Treatment Reviews. 2011;37(3):208-211. 2011
Lucia Del Mastro; Sara Giraudi; Alessia Levaggi; Paolo Pronzato
Medical approaches to preservation of fertility in female cancer patients
Expert Opinion on Pharmacotherapy. 2011;12(3):387-396. 2011
H.A. Azim; L. Del Mastro; G. Scarfone; F.A. Peccatori
Treatment of breast cancer during pregnancy: Regimen selection, pregnancy monitoring
and more ...
Breast. 2011;20(1):1-6. 2011
M. Lambertini; P. Pronzato; S. Giraudi; A. Levaggi; C. Bighin; L. del Mastro
Letrozole withdrawal response in locally advanced breast cancer
Annals of Oncology. 2011;22(8):1927-1928. 2010
2010
2010
2010
Claudia Bighin; Lucia Del Mastro; Giuseppe Canavese; Franca Carli; Paola Taveggia; Alessia Levaggi;
Sara Giraudi; Paolo Pronzato
Use in current clinical practice of 70-gene signature in early breast cancer
International Journal of Cancer. 2010;127(11):2736-2737. Claudia Bighin; Gianluigi Lunardi; Lucia del Mastro; Paola Marroni; Paola Taveggia; Alessia Levaggi; Sara
Giraudi; Paolo Pronzato
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated
with aromatase inhibitors
Oncologist. 2010;15(12):1270-1272. M. Venturini; C. Bighin; F. Puglisi; N. Olmeo; E. Aitini; G. Colucci; O. Garrone; A. Paccagnella; G. Marini;
L. Crinò; M. Mansutti; B. Baconnet; A. Barbato; L. Del Mastro
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with
trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
Breast. 2010;19(5):333-338. L. del Mastro; C. Bighin; G. Bini; S. Giraudi; P. Taveggia; A. Levaggi; G. Canavese; G. Rescinito; P.
Pronzato
Trastuzumab before breast surgery: Is concurrent administration with
anthracycline-containing chemotherapy necessary?
Annals of Oncology. 2010;21(6):1376-1377. 2010
P. Gascon; R. Pirker; L. Del mastro; L. Durrwell
Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced
non-small-cell lung cancer (NSCLC) receiving chemotherapy: Results of a phase II study
Annals of Oncology. 2010;21(10):2029-2039. 2009
Filippo Montemurro; Lucia Del Mastro; Massimo Aglietta
Reply to A. Sánchez-Muñoz et al
Journal of Clinical Oncology. 2009;27(35):e257-e258. 2009
2009
B. Banelli; I. Casciano; A. di Vinci; B. Gatteschi; A. Levaggi; F. Carli; C. Bighin; S. Salvi; G. Allemanni; P.
Ghiorzo; P. Pronzato; M. Venturini; M. Romani; L. del Mastro
Pathological and molecular characteristics distinguishing contralateral metastatic from new
primary breast cancer
Annals of Oncology. 2009;21(6):1237-1242. Anna Morabito; Beatrice Dozin; Sandra Salvi; Gennaro Pasciucco; Giuseppe Balbi; Stefania Laurent;
Simona Pastorino; Franca Carli; Mauro Truini; Paolo Bruzzi; Lucia Del Mastro; Maria Pia Pistillo
Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and
β2-microglobulin downregulation in breast cancer
Human Immunology. 2009;70(7):492-495. 2009
Filippo Montemurro; Massimo Aglietta; Lucia Del Mastro
Aromatase inhibitors as adjuvant therapy for breast cancer
Journal of Clinical Oncology. 2009;27(15):2566-2567. 2008
2008
2008
2008
Lucia Del Mastro
The difficult decision-making process for using or not using adjuvant chemotherapy in
premenopausal endocrine-responsive breast cancer patients
Annals of Oncology. 2008;19(7):1213-1215. Lucia Del Mastro; B. Dozin; E. Aitini; T. Catzeddu; E. Baldini; A. Contu; A. Durando; S. Danese; G.
Cavazzini; G. Canavese; P. Bruzzi; P. Pronzato; M. Venturini; G. Porcile; F. Testore; V. Mascia; E. De
Fraia; M. Botta; M. Merlano; M. Mencoboni; E. Campora; F. Brema; A. Lavarello; M. Campogrande; C.
Caroti; A. Falcone; S. Banducci; E. Villa; D. Aldighetti; M. Danova; U. Folco; E. Cortesi; G. D'Auria; N.
Olmeo; A. Pazzola; G. Mustacchi; C. Dellach
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: Findings
from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo
(GONO-MIG) Group
Annals of Oncology. 2008;19(2):299-307. Diana Crivellari; Zhuoxin Sun; Alan S. Coates; Karen N. Price; Beat Thürlimann; Henning Mouridsen;
Louis Mauriac; John F. Forbes; Robert J. Paridaens; Monica Castiglione-Gertsch; Richard D. Gelber;
Marco Colleoni; István Láng; Lucia Del Mastro; Laurence Gladieff; Manuela Rabaglio; Ian E. Smith;
Jacquie H. Chirgwin; Aron Goldhirsch
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early
breast cancer: The BIG 1-98 trial
Journal of Clinical Oncology. 2008;26(12):1972-1979. Patrizia Piccioli; Martina Serra; Simona Pedemonte; Giuseppe Balbi; Fabrizio Loiacono; Sonia Lastraioli;
Lucia Gargiulo; Anna Morabito; Daniela Zuccaro; Lucia Del Mastro; Maria Pia Pistillo; Marco Venturini;
Maria De Angioletti; Rosario Notaro
Hexaprimer amplification refractory mutation system PCR for simultaneous single-tube
genotyping of 2 close polymorphisms [8]
Clinical Chemistry. 2008;54(1):227-229. 2007
Lucia Del Mastro; Matteo Clavarezza; Marco Venturini
Reducing the risk of distant metastases in breast cancer patients: Role of aromatase
2007
2007
2007
2007
inhibitors
Cancer Treatment Reviews. 2007;33(8):681-687. Matteo Clavarezza; Lucia Del Mastro; Paolo Pronzato; Paolo Bruzzi; Marco Venturini
Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte
colony-stimulating factors during breast cancer adjuvant chemotherapy [2]
Journal of the National Cancer Institute. 2007;99(13):1050-1051. Cesare Gridelli; Matti S. Aapro; Sandro Barni; Giordano Domenico Beretta; Giuseppe Colucci; Bruno
Daniele; Lucia Del Mastro; Massimo Di Maio; Luigi De Petris; Francesco Perrone; Nick Thatcher; Filippo
De Marinis
Role of colony stimulating factors (CSFs) in solid tumours: Results of an expert panel
Critical Reviews in Oncology/Hematology. 2007;63(1):53-64. RC Coombes; LS Kilburn; CF Snowdon; R Paridaens; RE Coleman; SE Jones; J Jassem; CJH Van de
Velde; T Delozier; I Alvarez; L Del Mastro; O Ortmann; K Diedrich; AS Coates; E Bajetta; SB Holmberg;
D Dodwell; E Mickiewicz; J Andersen; PE Lønning; G Cocconi; J Forbes; M Castiglione; N Stuart; A
Stewart; LJ Fallowfield; G Bertelli; E Hall; RG Bogle; M Carpentieri; E Colajori; M Subar; E Ireland; JM
Bliss
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment
(Intergroup Exemestane Study): a randomised controlled trial
Lancet. 2007;369(9561):559-570. Alan S. Coates; Aparna Keshaviah; Beat Thürlimann; Henning Mouridsen; Louis Mauriac; John F. Forbes;
Robert Paridaens; Monica Castiglione-Gertsch; Richard D. Gelber; Marco Colleoni; István Láng; Lucia Del
Mastro; Ian Smith; Jacquie Chirgwin; Jean-Marie Nogaret; Tadeusz Pienkowski; Andrew Wardley; Erik H.
Jakobsen; Karen N. Price; Aron Goldhirsch
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for
postmenopausal women with endocrine-responsive early breast cancer: Update of study
BIG 1-98
Journal of Clinical Oncology. 2007;25(5):486-492. 2006
M. Venturini; L. Del Mastro
Safety of adjuvant aromatase inhibitor therapy
Cancer Treatment Reviews. 2006;32(7):548-556. 2006
Lucia Del Mastro; Tiziana Catzeddu; Marco Venturini
Infertility and pregnancy after breast cancer: Current knowledge and future perspectives
Cancer Treatment Reviews. 2006;32(6):417-422. 2006
Lucia Del Mastro; Marco Venturini
Fertility preservation strategies for breast cancer patients [3]
Journal of Clinical Oncology. 2006;24(25):4220-4221. 2006
M. Clavarezza; L. Del Mastro; M. Venturini
Taxane-containing chemotherapy in the treatment of early breast cancer patients
Annals of Oncology. 2006;17(SUPPL. 7):vii22-vii26. 2006
Lucia Del Mastro; T. Catzeddu; L. Boni; C. Bell; M.R. Sertoli; C. Bighin; M. Clavarezza; D. Testa; M.
Venturini
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with
goserelin in young, early breast cancer patients
Annals of Oncology. 2006;17(1):74-78. 2006
Gianfilippo Bertelli; Ornella Garrone; Marco Merlano; Marcella Occelli; Laura Bertolotti; Federico
2006
2005
2005
2005
2005
Castiglione; Fiorella Pepi; Ornella Fusco; Lucia Del Mastro; Robert C. F. Leonard
Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced
breast cancer
Oncology. 2006;69(6):471-477. M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Puglisi; O. Nicoletto; A.
Lambiase; L. Del Mastro
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as
first-line treatment for HER2-overexpressing metastatic breast cancer
Breast Cancer Research and Treatment. 2006;95(1):45-53. L. Del Mastro; F. Perrone
Reply to "Weekly paclitaxel in elderly breast cancer patients", by C. Smorenburg et al. (Ann
Oncol 2005; 16: 1979) [2]
Annals of Oncology. 2005;16(12):1979-1980. Marco Venturini; Lucia Del Mastro; Enrico Aitini; Editta Baldini; Cinzia Caroti; Antonio Contu; Franco
Testore; Fulvio Brema; Paolo Pronzato; Giovanna Cavazzini; Mario Roberto Sertoli; Giuseppe Canavese;
Riccardo Rosso; Paolo Bruzzi
Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a
randomized trial
Journal of the National Cancer Institute. 2005;97(23):1724-1733. Gianfilippo Bertelli; Ornella Garrone; Laura Bertolotti; Marcella Occelli; Serafino Conforti; Nicola Marzano;
Antonio Febbraro; Paolo Carlini; Christina Liossi; Lucia Del Mastro; Robert C.F. Leonard
Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced
breast cancer
Oncology. 2005;68(4-6):364-370. L. Del Mastro; P. Bruzzi; G. Nicolo; G. Cavazzini; A. Contu; M. D'Amico; A. Lavarello; F. Testore; B.
Castagneto; E. Aitini; L. Perdelli; C. Bighin; R. Rosso; Marco Venturini
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant
chemotherapy in breast cancer patients
British Journal of Cancer. 2005;93(1):7-14. 2005
Gilberto De Castro Jr.; Lucia Del Mastro; Marco Venturini; A. Howell
ATAC trial update [1] (multiple letters)
Lancet. 2005;365(9466):1225-1226. 2005
2005
Lucia Del Mastro; F. Perrone; L. Repetto; L. Manzione; V. Zagonel; L. Fratino; D. Marenco; M. Venturini;
E. Maggi; C. Bighin; T. Catzeddu; A. Venturino; R. Rosso
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: A
phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
Annals of Oncology. 2005;16(2):253-258. Paolo Bruzzi; Lucia Del Mastro; Maria P. Sormani; Lars Bastholt; Marco Danova; Christian Focan; George
Fountzilas; James Paul; Riccardo Rosso; Marco Venturini
Objective response to chemotherapy as a potential surrogate end point of survival in
metastatic breast cancer patients
Journal of Clinical Oncology. 2005;23(22):5117-5125. 2004
Tiziana Catzeddu; Gianfilippo Bertelli; Lucia Del Mastro; Marco Venturini
Sentinel Lymph Node Biopsy in Breast Cancer Patients: The Medical Oncology Perspective
Journal of Surgical Oncology. 2004;85(3):129-132. 2004
Lucia Del Mastro
The AIOM (Italian Association of Medical Oncology) practice guidelines for breast
neoplasms
Tumori. 2004;90(2):1-8. 2004
Lazzaro Repetto; Danila Comandini; Sonia Mammoliti; Maria Pietropaolo; Lucia del Mastro
Weekly paclitaxel in elderly patients with advanced breast cancer: A dose-finding study
Drugs in R and D. 2004;5(1):11-15. 2003
2003
2003
2002
2002
G. Lunardi; M.O. Vannozzi; C. Bighin; L. Del Mastro; I. Stevani; G. Schettini; Marco Venturini
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer
patients
Annals of Oncology. 2003;14(8):1222-1226. Lucia Del Mastro
Epoetin in cancer patients. Guidelines of the ASCO and the ASH for evidence-based clinical
practice
Tumori. 2003;89(4):1-12. Marco Venturini; Antonio Durando; Ornella Garrone; Maria Antonietta Colozza; Antonio Contu; Ilaria
Stevani; Franco Genta; Claudia Bighin; Antonio Lambiase; Lucia Del Mastro
Capecitabine in combination with docetaxel and epirubicin in patients with previously
untreated, advanced breast carcinoma
Cancer. 2003;97(5):1174-1180. G. Bertelli; M. Venturini; L. Del Mastro; M. Bergaglio; P. Sismondi; N. Biglia; S. Venturini; G. Porcile; P.
Pronzato; M. Costantini; R. Rosso
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of
postmenopausal hot flashes in breast cancer patients: A randomised study
Annals of Oncology. 2002;13(6):883-888. L. Del Mastro; M. Costantini; G. Morasso; F. Bonci; M. Bergaglio; S. Banducci; P. Viterbori; P. Conte; R.
Rosso; M. Venturini
Impact of two different dose-intensity chemotherapy regimens on psychological distress in
early breast cancer patients
European Journal of Cancer. 2002;38(3):359-366. 2002
Lucia Del Mastro; Elisa Maggi; Tiziana Catzeddu; Abdolraim Hazini; Carol Bell
Is it possible to use anthracyclines in patients older than 70 years? Contra
Tumori. 2002;88(SUPPL. 1):S136-S137. 2002
2002
2001
M. Venturini; L. Del Mastro; O. Garrone; C. Angiolini; M. Merlano; M. Bergaglio; G. Tolino; A. Lambiase;
A. Baldini; G. Canavese; R. Rosso
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as
first-line chemotherapy for advanced breast cancer
Annals of Oncology. 2002;13(4):546-552. G. Lunardi; M. Venturini; M.O. Vannozzi; G. Tolino; L. Del Mastro; C. Bighin; G. Schettini; M. Esposito
Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic
behaviour of both drugs in advanced breast cancer
Annals of Oncology. 2002;13(2):280-285. L. Del Mastro; M. Venturini; R. Lionetto; F. Carnino; D. Guarneri; L. Gallo; A. Contu; P. Pronzato; L.
Vesentini; M. Bergaglio; S. Comis; R. Rosso
2001
2001
2001
Accelerated-intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) compared
with standard CEF in metastatic breast cancer patients: Results of a multicenter,
randomized phase III study of the Italian gruppo oncologico nord-quest-mammella inter
gruppo group
Journal of Clinical Oncology. 2001;19(8):2213-2221. M. Venturini; A. Michelotti; P. Papaldo; L. Del Mastro; M. Bergaglio; R. Lionetto; G. Lunardi; C. Sguotti;
L. Frevola; S. Donati; R. Rosso; F. Cognetti
Identification of the highest dose of docetaxel associable with active doses of epirubicin.
Results from a dose-finding study in advanced breast cancer patients
Annals of Oncology. 2001;12(8):1097-1106. L. Del Mastro; M. Venturini; C. Viscoli; M. Bergaglio; A. Signorini; C. Bighin; G. Bertelli; C. Semino; G.
Pietra; S. Bertoglio; M.R. Sertoli; A. Lambiase; R. Rosso; G. Melioli
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in
breast cancer patients
Annals of Oncology. 2001;12(4):505-508. G. Sanguineti; L. Del Mastro; M. Guenzi; P. Ricci; M. Cavallari; G. Canavese; I. Stevani; M. Venturini
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast
conserving surgery
Annals of Oncology. 2001;12(3):373-378. 2001
G. Morasso; M. Costantini; P. Viterbori; F. Bonci; L. Del Mastro; M. Musso; O. Garrone; M. Venturini
Predicting mood disorders in breast cancer patients
European Journal of Cancer. 2001;37(2):216-223. 2001
2001
2001
2001
2001
Paolo Pronzato; Paola Queirolo; Stefania Vecchio; Rita Lionetto; Lucia Del Mastro; Marco Venturini;
Giovanni Gardin; Angela Alama; Mario R. Sertoli
Thymidine labeling index analysis in early breast cancer patients randomized to receive
perioperative chemotherapy
Oncology. 2001;60(1):88-93. Lucia Del Mastro
Dose-dense sequential administration and same day administration of epirubicin and
paclitaxel yield similar response rates in women with advanced breast cancer
Evidence-based Oncology. 2001;2(4):211-213. M. Valenzano; G.F. Bertelli; S. Costantini; A. Corticelli; L. Del Mastro; R. Paoletti; O. Garrone; R. Rissone
Transvaginal ultrasonography and hysterosonography to monitor endometrial effects in
tamoxifen-treated patients
European Journal of Gynaecological Oncology. 2001;22(6):441-444. R. Rosso; L. Del Mastro; A. Durando; O. Garrone; R. Cherubini; T. Scotto; F. Genta; M. Occelli; R.
Bellino; C. Bighin; T. Catzeddu; I. Stevani; A. Baldini; A. Lambiase; M. Venturini
Capecitabine in association with epirubicin and docetaxel as a first line treatment in
advanced breast cancer a multicenter phase II study
Breast Cancer Research and Treatment. 2001;69(3):270. M. Venturini; A. Michelotti; P. Papaldo; L. Del Mastro; M. Bergaglio; R. Lionetto; G. Lunardi; C. Sguotti;
L. Frevola; S. Donati; R. Rosso; F. Cognetti
Erratum: Identification of the highest dose of docetaxel associable with active doses of
epirubicin. Results from a dose-finding study in advanced breast cancer patients (Annals of
Oncology (2001) vol. 12 (8) (1097-1106))
Annals of Oncology. 2001;12(10):1498. 2000
2000
2000
1999
1999
Marco Venturini; Gianluigi Lunardi; Lucia Del Mastro; Maria Ornella Vannozzi; Giuseppina Tolino;
Gianmauro Numico; Maurizio Viale; Ilaria Pastrone; Catia Angiolini; Gianfilippo Bertelli; Manuela Straneo;
Riccardo Rosso; Mauro Esposito
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity
Journal of Clinical Oncology. 2000;18(10):2116-2125. Andrea Michelotti; Marco Venturini; Carmelo Tibaldi; Carmelo Bengala; Luigi Gallo; Flavio Carnino; Lucia
Del Mastro; Rita Lionetto; Elda Montanaro; Riccardo Rosso; Pierfranco Conte
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
Breast Cancer Research and Treatment. 2000;59(2):133-139. G. Bertelli; P. Queirolo; S. Vecchio; C. Angiolini; M. Bergaglio; L. Del Mastro; A. Signorini; M. Valenzano;
M. Venturini
Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients
Anticancer Research. 2000;20(5 C):3659-3662. Massimo Costantini; Marco Musso; Paola Viterbori; Francesca Bonci; Lucia Del Mastro; Ornella Garrone;
Marco Venturini; Gabriella Morasso
Detecting psychological distress in cancer patients: Validity of the Italian version of the
Hospital Anxiety and Depression Scale
Supportive Care in Cancer. 1999;7(3):121-127. MD Esposito; Marco Venturini; M.O. Vannozzi; G. Tolino; G. Lunardi; O. Garrone; C. Angiolini; M. Viale;
M. Bergaglio; L. Del Mastro; R. Rosso
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of
epirubicin in breast cancer patients
Journal of Clinical Oncology. 1999;17(4):1132-1140. 1999
T. Corcoran; L. Del Mastro; M. Venturini; G.N. Hortobagyi
Treatment of breast cancer [2] (multiple letters)
New England Journal of Medicine. 1999;340(4):319-320. 1999
1998
1998
L. Del Mastro; A. Gennari; S. Donati
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of
anemia
Annals of Oncology. 1999;10(SUPPL. 5):S91-S94. D. Dini; L. Del Mastro; A. Gozza; R. Lionetto; O. Garrone; G. Forno; G. Vidili; G. Bertelli; M. Venturini
The role of pneumatic compression in the treatment of postmastectomy lymphedema. A
randomized phase III study
Annals of Oncology. 1998;9(2):187-190. P.F. Conte; L. Del Mastro
Putting the taxanes to work: unanswered questions.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le
cancer. 1998;152:305-313. 1998
Lucia Del Mastro; Marco Venturini
Strategies for the use of epoetin alfa in breast cancer patients
Oncologist. 1998;3(5):314-318. 1998
M. Venturini; L. Del Mastro; M. Picart
More on dose-intensity of anthracyclines in breast cancer [1] (multiple letters)
1998
1997
Annals of Oncology. 1998;9(4):461. Gianfilippo Bertelli; Marco Venturini; Lucia Del Mastro; Ornella Garrone; Maurizio Cosso; Claudio
Gustavino; Enzo Cusimano; Tiziana Guido; Guido Nicolò; Riccardo Rosso
Tamoxifen and the endometrium: Findings of pelvic ultrasound examination and
endometrial biopsy in asymptomatic breast cancer patients
Breast Cancer Research and Treatment. 1998;47(1):41-46. Lucia Del Mastro; Marco Venturini; Rita Lionetto; Ornella Garrone; Giovanni Melioli; Wanda Pasquetti;
Mario Roberto Sertoli; Gianfilippo Bertelli; Giuseppe Canavese; Massimo Costantini; Riccardo Rosso
Randomized phase III trial evaluating the role of erythropoietin in the prevention of
chemotherapy-induced anemia
Journal of Clinical Oncology. 1997;15(7):2715-2721. 1997
Riccardo Rosso; Lucia Del Mastro; Marco Venturini; Marina Bergaglio; Wanda Pasquetti; Ornella Garrone
Use of erythropoietin in oncology
Tumori. 1997;83(4 SUPPL. 2):S26-S30. 1997
1997
1996
Lucia Del Mastro; Marco Venturini; Mario Roberto Sertoli; Riccardo Rosso
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: Prognostic
role and clinical implications
Breast Cancer Research and Treatment. 1997;43(2):183-190. L. Del Mastro; M. Venturini; M. Costantini; O. Garrone; M.R. Sertoli; G. Bertelli; A.M. Machi; R. Rosso
Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with
β-Thalassemia minor [1]
Journal of the National Cancer Institute. 1997;89(6):455-456. M. Venturini; P. Bruzzi; L. Del Mastro; O. Garrone; G. Bertelli; M. Guelfi; S. Pastorino; R. Rosso; M.R.
Sertoli
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy
of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic
breast cancer
Journal of Clinical Oncology. 1996;14(3):764-773. 1996
Marco Venturini; Lucia Del Mastro; Ornella Garrone; Marina Bergaglio; Riccardo Rosso
The mobilization of peripheral blood progenitor cells with conventional chemotherapy
Tumori. 1996;82(2 SUPPL.):S14-S18. 1996
1996
1995
Marco Venturini; Lucia Del Mastro; Franco Testore; Marco Danova; Ornella Garrone; Claudio Lanfranco;
Fabio Latini; Mario R. Sertoli; Rita Lionetto; Paola Queirolo; Andrea Ardizzoni; Riccardo Rosso
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration
and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: A
dose-finding study in patients with advanced breast cancer
Cancer Chemotherapy and Pharmacology. 1996;38(6):487-494. M. Venturini; A. Michelotti; L. Del Mastro; L. Gallo; F. Carnino; O. Garrone; C. Tibaldi; N. Molea; R.C.
Bellina; P. Pronzato; P. Cyrus; J. Vinke; F. Testore; M. Guelfi; R. Lionetto; P. Bruzzi; P.F. Conte; R. Rosso
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane
versus no cardioprotection in women receiving epirubicin chemotherapy for advanced
breast cancer
Journal of Clinical Oncology. 1996;14(12):3112-3120. M.R. Sertoli; P. Bruzzi; P. Pronzato; P. Queirolo; D. Amoroso; L. Del Mastro; M. Venturini; A. Vigani; G.
Bertelli; E. Campora; F. Boccardo; C. Monzeglio; E. Paganini; G. Pastorino; G. Canavese; A. Catturich; F.
1995
1995
1995
1994
1994
1994
1994
1993
1993
Cafiero; C. Vecchio; P. Miccoli; A. Rubagotti; R. Rosso
Randomized cooperative study of perioperative chemotherapy in breast cancer
Journal of Clinical Oncology. 1995;13(11):2712-2721. L. Del Mastro; M. Constantini; A.R. Bianco; M.D. Newman; R.A. Evans; G. Bonadonna; P. Valagussa; I.C.
Henderson
Adjuvant chemotherapy in breast cancer [2]
New England Journal of Medicine. 1995;333(9):596-597. L. Del Mastro; M. Venturini; P.G. Giannessi; A. Vigani; O. Garrone; F. Carnino; P. Russo; P. Galletti; R.
Rosso; P.F. Conte
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in
neoplastic ascites: A feasibility study
Anticancer Research. 1995;15(5 B):2207-2212. G. Bertelli; A. Gozza; G.B. Forno; M.G. Vidili; S. Silvestro; M. Venturini; L. Del Mastro; O. Garrone; R.
Rosso; D. Dini
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of
vesicant cytotoxic drugs: A prospective clinical study
Journal of Clinical Oncology. 1995;13(11):2851-2855. M. Venturini; L. Del Mastro; G. Melioli; E. Balleari; O. Garrone; W. Pasquetti; C. Bason; R. Ghio; P.
Bruzzi; R. Rosso
Release of peripheral blood progenitor cells during standard dose cyclophosphamide,
epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast
cancer therapy
Cancer. 1994;74(8):2300-2306. L. Del Mastro; O. Garrone; M. Guenzi; F. Cafiero; G. Nicolo; R. Rosso; M. Venturini
Angiosarcoma of the residual breast after conservative surgery and radiotherapy for
primary carcinoma
Annals of Oncology. 1994;5(2):163-165. F. Perrone; S. De Placido; C. Carlomagno; A. Gravina; M. De Laurentiis; L. Del Mastro; C. Gridelli; C.
Pagliarulo; A.R. Bianco
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer
patients: A phase II study
American Journal of Clinical Oncology: Cancer Clinical Trials. 1994;17(3):218-222. L. Del Mastro; O. Garrone; M.R. Sertoli; G. Canavese; A. Catturich; M. Guenzi; R. Rosso; M. Venturini
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus
granulocyte colony stimulating factor as adjuvant therapy in early breast cancer
European Journal of Cancer. 1994;30(5):606-610. O. Garrone; L. Del Mastro; G.L. Mariani; A. Ardizzoni; M. Venturini; R. Rosso
Cyclophosphamide, methotrexate and 5-fluorouracil administered intravenously with and
without granulocyte-colony stimulating factor in adjuvant breast cancer
Minerva Medica. 1993;84(9):467-472. M. Venturini; L. Del Mastro; A. Ardizzoni; M.R. Sertoli; G.L. Mariani; M.C. Pennucci; O. Garrone; S.
Silvestro; G.F. Addamo; P. Queirolo; R. Rosso
High dose intensity chemotherapy without bone marrow support: Role of
granulocyte-macrophage colony-stimulating factor
Annals of the New York Academy of Sciences. 1993;698:389-397. 1993
1991
1990
A.R. Bianco; S. De Placido; F. Perrone; C. Carlomagno; M. De Laurentiis; L. Del Mastro; R. Lauria; A.
Marinelli; C. Gallo
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer
Annals of the New York Academy of Sciences. 1993;698:330-338. A.R. Bianco; L. Del Mastro; C. Gallo; F. perrone; E. Matano; C. pagliarulo; S. De Placido
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal
patients with early breast cancer
British Journal of Cancer. 1991;63(5):799-803. Sabino De Placido; Ciro Gallo; Alfredo Marinelli; Francesco Perrone; Clorindo Pagliarulo; Giuseppe
Petrella; Giovanni Delrio; Michela D'Istria; Lucia Del Mastro; Angelo Raffaele Bianco
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer - Ten year
results of the Naples (GUN) study
Breast Cancer Research and Treatment. 1990;16(2):111-117. © 2016 Elsevier B.V All rights reserved. SciVal ® is a registered trademark of Elsevier Properties SA | About SciVal Experts | Terms and
conditions | Privacy statement | Contact